IL6 and gastric cancer: Another study demonstrated that CAF-mediated activation of the JAK-STAT signaling pathway could confer chemotherapy resistance to gastric cancer cells, while IL-6 secreted by CAFs could protect gastric cancer cells through a paracrine signaling pathway [91].